Exploring the isoform selectivity of TGX-221 related pyrido[1,2-a]pyrimidinone-based Class IA PI 3-kinase inhibitors: Synthesis, biological evaluation and molecular modelling-Reference-Cited by-同舟云学术

Exploring the isoform selectivity of TGX-221 related pyrido[1,2-a]pyrimidinone-based Class IA PI 3-kinase inhibitors: Synthesis, biological evaluation and molecular modelling

Published:2015-07 Issue:13 Volume:23 Page:3796-3808
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Marshall Andrew J.,Lill Claire L.,Chao Mindy,Kolekar Sharada V.,Lee Woo-Jeong,Marshall Elaine S.,Baguley Bruce C.,Shepherd Peter R.,Denny William A.,Flanagan Jack U.,Rewcastle Gordon W.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference62 articles.

1. PI3-kinase inhibition: a target for drug development?

2. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin

3. Phosphoinositide 3-kinase inhibition in cancer treatment

4. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

5. Synthesis and Function of 3-Phosphorylated Inositol Lipids

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of Pyrido[1,2-a]pyrimidin-4-one derivatives as novel allosteric SHP2 inhibitors;Bioorganic Chemistry;2024-10

2. Microwave assisted synthesis, acetylcholinesterase inhibition and molecular docking studies of furo[2,3‐d]pyrido[1,2‐a]pyrimidin‐4‐one derivatives;Journal of Heterocyclic Chemistry;2024-07-17

3. Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta;iScience;2024-06

4. Synthesis and biological evaluation of 4H-benzo[e][1,3]oxazin-4-ones analogues of TGX-221 as inhibitors of PI3Kβ;Bioorganic & Medicinal Chemistry;2022-09

5. Berberine and Its Main Metabolite Berberrubine Inhibit Platelet Activation Through Suppressing the Class I PI3Kβ/Rasa3/Rap1 Pathway;Frontiers in Pharmacology;2021-10-08